METROMICON-NEO
- Registration number:ЛП-001676
- International non-proprietary name:metronidazole + miconazole
- Pharmaceutical form:vaginal suppositories
- Pharmacotherapeutic group:combination antimicrobial agent (antimicrobial and antiprotozoal + antifungal agent)
- Dosage form:vaginal suppositories 2,000 mg No. 14
- Composition:active substance: metronidazole 500 mg, miconazole nitrate - 100 mg
METROMICON-NEO is a combination drug with antiprotozoal, antifungal, and antibacterial action.
- Indications for use:
-
- bacterial vaginosis;
- trichomonas vaginitis and vulvovaginitis;
- vaginal candidiasis;
- mixed vaginal infection.
- Method of administration and posology:
-
Intravaginally.
- acute vaginitis, bacterial vaginosis: 1 suppository in the morning and for a night for 7 consecutive days;
- chronic vaginitis: 1 suppository once daily immediately before sleep for 14 consecutive days;
-
- often recurrent vaginitis or lack of positive clinical dynamics in treatment with other methods: 1 suppository in the morning and for a night for 14 days.
- Shelf life:
-
3 years. Do not use after the expiry date.
- Manufacturer
- LLC "Avexima Siberia"
We recommend
-
Antimicrobial agent
-
-
-
-
antiviral agent, aciclovir
-
Antifungal agents
-
Combination antimicrobial agent
-
Antimicrobial and antiprotozoal agent.
-
Combination drug
-
Antiviral drug
-
Coronary dilating drug
-
-
-
Enterosorbent.
-
Antiepileptic agent
-
Spasmolytic agent
-
Enzyme product
-
Metabolic agent
-
-
Combination drug
-
Antimicrobial and antiprotozoal agent
-
Antimicrobial agent
-
NOBAZIT®
-
Antifungal agent
-
Analgesic agent
-
Antimicrobial agent
-
Potassium and magnesium preparation
-
-
Calcium channel blocker
-
Antimicrobial agent
-
Antifungal agent
-
Antimicrobial agent
-
Non-steroidal anti-inflammatory drug (NSAID)